Australie - anglais - Department of Health (Therapeutic Goods Administration)

orthotic & prosthetic centre pty ltd - 41038 - orthosis, head, helmet - helmet designed to provide head protection in case of impact and support in cases of skull abnormality.

Australie - anglais - Department of Health (Therapeutic Goods Administration)

stryker australia pty ltd - 35102 - helmet, surgical, system - intended to protect the patient, health care personnel and operating room personnel against contamination, exposure of infectious bodily fluids, and the transfer of microorganism and particulate material.

Australie - anglais - Department of Health (Therapeutic Goods Administration)

allied health group australia - 41038 - orthosis, head, helmet - treatment of diagnosed with deformational plagiocephaly, brachycephaly or scaphocephaly and is less than 12 months old, cranial remolding may be prescribed to correct the shape of the baby's head. helmets must be prescribed by a licensed physician.

Australie - anglais - Department of Health (Therapeutic Goods Administration)

stryker australia pty ltd -

Australie - anglais - Department of Health (Therapeutic Goods Administration)

ecolab pty ltd -

Australie - anglais - Department of Health (Therapeutic Goods Administration)

ecolab pty ltd -

Australie - anglais - Department of Health (Therapeutic Goods Administration)

healthsaver pty ltd - 41038 - orthosis, head, helmet - a protective head device intended to minimize harm in the case of a fall.

Australie - anglais - Department of Health (Therapeutic Goods Administration)

plexus ra pty ltd - 41038 - orthosis, head, helmet - n-pro is described as a - patent pending - non-invasive device, comprised of viscoelastic materials, intended to be used to protect the skull from non-penetrating direct impacts in rugby and for the medical purpose of preventing or alleviating head trauma, specifically mild traumatic brain injury (mtbi). the device provides impact protection for rugby players (at all playing levels) to the occipital, parietal, temporal, frontal, mastoid and sphenoid regions of the skull by dissipating the impact energy at the localised site of impact (coup), minimising the brain?s movement and deformation, thus reducing the incidence of tissue damage at both the coup and contre - coup sites.

États-Unis - anglais - NLM (National Library of Medicine)

medimetriks pharmaceuticals, inc. - ciclopirox olamine (unii: 50md4sb4ap) (ciclopirox - unii:19w019zdrj) - ciclopirox 7.7 mg in 1 ml - loprox® topical suspension is indicated for the topical treatment of the following dermal infections: tinea pedis, tinea cruris, and tinea corporis due to trichophyton rubrum, trichophyton mentagrophytes, epidermophyton floccosum, and microsporum canis; ; cutaneous candidiasis (moniliasis) due to candida albicans; and tinea (pityriasis) versicolor due to malassezia furfur. loprox® topical suspension is contraindicated in individuals who have shown hypersensitivity to any of its components.

États-Unis - anglais - NLM (National Library of Medicine)

medimetriks pharmaceuticals, inc. - ciclopirox olamine (unii: 50md4sb4ap) (ciclopirox - unii:19w019zdrj) - ciclopirox 7.7 mg in 1 g - loprox® cream is indicated for the topical treatment of the following dermal infections: tinea pedis, tinea cruris, and tinea corporis due to trichophyton rubrum, trichophyton mentagrophytes, epidermophyton floccosum, and microsporum canis; candidiasis (moniliasis) due to candida albicans; and tinea (pityriasis) versicolor due to malassezia furfur. loprox® cream is contraindicated in individuals who have shown hypersensitivity to any of its components.